The global Galactosemia Treatment Industry is on a path of significant growth, driven by increasing awareness, mandatory newborn screening programs, and the accelerating development of novel therapeutic approaches. Galactosemia, a rare genetic metabolic disorder, necessitates lifelong management, primarily through a restricted diet, which fuels the demand for specialized nutritional...